Axa S.A. Tyra Biosciences, Inc. Transaction History
Axa S.A.
- $29.5 Billion
- Q1 2025
A detailed history of Axa S.A. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Axa S.A. holds 128,189 shares of TYRA stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,189Holding current value
$1.41 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
123Shares Held
55.1MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$117 Million2.05% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$45 Million90.83% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$44.7 Million8.77% of portfolio
-
Nextech Invest Ag4.06MShares$44.7 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$43.5 Million1.61% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $463M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...